ProtoQSAR is a company of computational chemistry, specialized in the development and optimization of active compounds in diverse areas, like pharmacy, cosmetic or functional food. Our computer models are also an efficient alternative that allows the replacement of animal tests for compliance with regulatory standards such as the REACH regulation of the European Union. Read more
"Drug discovery", virtual screening, drug repositioning, ADME-T properties prediction, etc.
REACH, ICH, CLP...
Computational evaluation of the properties required by different regulations in force
List of QSAR models available for the prediction of physico-chemical, (eco) toxicological parameters, etc.
We participate in projects on REACH, biocides, nanomaterials, endocrine disruptors, etc.
Webinar: Use of ProtoPRED for in silico risk assessment under REACH and ICH M7
You can check our recently released webinar “Use of ProtoPRED for in silico risk assessment under REACH and ICH M7”. In this webinar, we discuss the applications of our computational tool ProtoPRED, with a special focus on the ProtoREACH and ProtoICH modules. ProtoREACH is a computational tool specifically focused on REACH, a European Union regulation […]
ProtoQSAR in different congresses!
ProtoQSAR presence in different congresses! In the last months, our team has been able to participate in different congresses by attending and, sometimes, presenting our work. Our CTO Eva Serrano Candelas presented a poster at the ONE conference by online modality. In this work, Eva presented the results of a project on Endocrine Disruption using […]
European night of researchers
ProtoQSAR participates in the European researchers’ night. Last Friday, September 30, the European researchers’ night was celebrated. On the occasion of this celebration, our researchers Salvador Moncho Escrivà and José Luís Vallés Pardo participated in the Mediterranean night of the MEDNIGHT researchers. This initiative, organized by scientific institutions in the Mediterranean area, organized different activities […]
Subscribe to our Newsletter